Lenk Robert P

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$68,175.39
Insider Sells Quantity
1
Insider Sells Sum
$472.05

Insider Activity of Lenk Robert P

According to the SEC Form 4 filings, Lenk Robert P, being in a position of

  1. director at Plus Therapeutics, Inc.,
    оver the last 12 months, has bought 28761 share for $47,700, and sold 0 shares,
    over all time since 2020-08-25, has bought 38761 share for $68,175, and sold 1500 shares for $472.

The largest purchase of all time was on 2021-09-13 and amounted to 7000 shares of Plus Therapeutics, Inc. for $13,011.

The largest sale of all time was on 2022-12-30 and amounted to 1500 shares of Plus Therapeutics, Inc. for $472.

Biography of Lenk Robert P

No biography is available at this moment.

2024-05-08PurchasePlus Therapeutics, Inc.
PSTV
director
4,167
0.0876%
$2.04$8,501-29.74%
2023-11-16PurchasePlus Therapeutics, Inc.
PSTV
director
1,000
0.02%
$1.95$1,950-15.98%
2023-11-15PurchasePlus Therapeutics, Inc.
PSTV
director
1,000
0.0206%
$1.77$1,770-1.6%
2023-11-13PurchasePlus Therapeutics, Inc.
PSTV
director
4,000
0.086%
$1.43$5,720+25.17%
2023-11-10PurchasePlus Therapeutics, Inc.
PSTV
director
2,000
0.0452%
$1.45$2,900+30.96%
2023-11-09PurchasePlus Therapeutics, Inc.
PSTV
director
4,199
0.0971%
$1.59$6,676+23.32%
2023-11-08PurchasePlus Therapeutics, Inc.
PSTV
director
5,000
0.1147%
$1.65$8,250+15.72%
2023-11-07PurchasePlus Therapeutics, Inc.
PSTV
director
6,000
0.1303%
$1.64$9,840+11.52%
2023-11-06PurchasePlus Therapeutics, Inc.
PSTV
director
1,395
0.0286%
$1.50$2,093+13.98%
2022-12-30SalePlus Therapeutics, Inc.
PSTV
director
1,500
0.0004%
$0.31$472-41.88%
2021-09-13PurchasePlus Therapeutics, Inc.
PSTV
director
7,000
0.0036%
$1.86$13,011-45.9%
2020-08-25PurchasePlus Therapeutics, Inc.
PSTV
director
3,000
0.0046%
$2.49$7,465-3.47%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.